| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/03/1996 | EP0690126A1 Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
| 01/03/1996 | EP0690071A2 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 01/03/1996 | EP0689845A2 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| 01/03/1996 | EP0689606A1 ANTIBODIES AND ASSAYS FOR DETERMINING MUTATIONS IN THE $i(APC) GENE |
| 01/03/1996 | EP0689605A1 Hepatitis b escape mutant specific binding molecules |
| 01/03/1996 | EP0689600A1 Process to induce the death of tumor cells |
| 01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
| 01/03/1996 | EP0689597A1 USE OF PORCINE GAL $g(a)(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
| 01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/03/1996 | EP0689590A1 Totally synthetic affinity reagents |
| 01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 01/03/1996 | EP0689552A1 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 01/03/1996 | EP0689550A1 Novel antimicrobial peptides from bovine neutrophils |
| 01/03/1996 | EP0689459A1 Novel agent for controlling cell activity |
| 01/03/1996 | EP0689455A1 Therapeutic strategies for immunoinfective cluster virus infections |
| 01/03/1996 | EP0498851B1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 01/03/1996 | EP0444158B1 Conjugated polypeptides and methods for their preparation and use |
| 01/03/1996 | EP0440686B1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
| 01/03/1996 | EP0317622B1 Prevention and treatment of retroviral disease |
| 01/03/1996 | EP0316440B1 System and method for providing localized Mössbauer absorption in an organic medium |
| 01/02/1996 | US5480981 Hodgkin's disease |
| 01/02/1996 | US5480974 Blocking agents, antiinflammatory |
| 01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
| 01/02/1996 | US5480895 Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof |
| 01/02/1996 | US5480799 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
| 01/02/1996 | US5480793 Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension |
| 12/28/1995 | WO1995035379A1 66 kDa ANTIGEN FROM BORRELIA |
| 12/28/1995 | WO1995035375A1 Interleukin-5 specific recombinant antibodies |
| 12/28/1995 | WO1995035374A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 12/28/1995 | WO1995035321A1 Antibodies against t-cells as therapeutics |
| 12/28/1995 | WO1995035120A1 Monoclonal antibodies for the reduction of anti-xenogeneic immune responses |
| 12/28/1995 | WO1995035119A1 METHODS AND COMPOSITIONS INCLUDING A 13 kD B. BURGDORFERI PROTEIN |
| 12/28/1995 | WO1995035114A1 Borrelia burgdorferi exported plasmid protein a, nucleic acids encoding thereof, and uses thereof |
| 12/28/1995 | WO1995035111A2 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
| 12/28/1995 | WO1995020664A3 Mammalian expression systems for hepatitis c virus envelope genes |
| 12/28/1995 | WO1995015982A3 Process for generating specific antibodies |
| 12/28/1995 | CA2193682A1 Methods and compositions including a 13 kd b. burgdorferi protein |
| 12/28/1995 | CA2193092A1 Antibodies against t cells as therapeutics |
| 12/28/1995 | CA2192827A1 Use of .beta.galnac(1-4).beta.gal conjugates to treat candida infection |
| 12/27/1995 | EP0688361A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 12/27/1995 | EP0688360A1 Bone stimulating factor |
| 12/27/1995 | EP0688338A1 T cell epitopes of ryegrass pollen allergen |
| 12/27/1995 | EP0688334A1 Oligodendroglial trophic factor and methods of use thereof |
| 12/27/1995 | EP0688316A1 Coupling method using selective amination of maleimide |
| 12/27/1995 | EP0688228A1 COMPOSITONS COMPRISING IgG 3? ANTIBODIES |
| 12/27/1995 | EP0688223A1 $i(IN VITRO) ASSAY MEASURING DEGREE OF ACTIVATION OF IMMUNE CELLS |
| 12/27/1995 | EP0559795B1 Methods for the diagnosis of chronic lower back and cervical pain |
| 12/27/1995 | EP0550650B1 Antagonists of human gamma interferon |
| 12/26/1995 | US5478926 Monoclonal antibody against human IgE |
| 12/26/1995 | US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors |
| 12/26/1995 | US5478741 Antibodies to the HRPII protein of plasmodium falciparum |
| 12/26/1995 | US5478740 Hybridomas and monoclonal antibodies which specifically bind human basic fibroblast growth factor |
| 12/26/1995 | US5478727 Methods and compositions for the preparation and use of a herpes protease |
| 12/26/1995 | US5478725 Contacting endometrium sample with monoclonal antibody specific for integrin, assaying, correlating absence with endometriosis |
| 12/26/1995 | US5478558 Administering composition free of serum amyloid P, thrombin activity, infectious agents, antibodies |
| 12/26/1995 | CA1337800C Monoclonal antibody recognizing alpha 2 --> 3 bonds |
| 12/21/1995 | WO1995034817A1 Positive and positive/negative cell selection mediated by peptide release |
| 12/21/1995 | WO1995034655A2 Surface protein of staphylococcus aureus |
| 12/21/1995 | WO1995034652A1 Calcium binding recombinant antibody against protein c |
| 12/21/1995 | WO1995034650A2 Mn gene and protein |
| 12/21/1995 | WO1995034648A1 A method for displaying proteins |
| 12/21/1995 | WO1995034638A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 12/21/1995 | WO1995034635A1 Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum |
| 12/21/1995 | WO1995034581A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
| 12/21/1995 | WO1995034580A1 Isolated nucleic acid encoding retinol dehydrogenase |
| 12/21/1995 | WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 12/21/1995 | WO1995034320A2 Methods for inhibiting antigen specific t cell responses |
| 12/21/1995 | WO1995034319A1 Compositions and methods for the treatment of tumors |
| 12/21/1995 | WO1995033048A3 P2x receptors (purinoceptor family) |
| 12/21/1995 | WO1995030750A3 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 12/21/1995 | WO1995027066A3 Dna encoding ubiquitin conjugating enzymes |
| 12/21/1995 | CA2193060A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
| 12/21/1995 | CA2192655A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 12/21/1995 | CA2192334A1 Isolated nucleic acid encoding retinol dehydrogenase |
| 12/21/1995 | CA2192175A1 Surface protein of staphylococcus aureus |
| 12/21/1995 | CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 12/21/1995 | CA2191733A1 Methods for inhibiting antigen specific t cell responses |
| 12/21/1995 | CA2191065A1 Compositions and methods for the treatment of tumors |
| 12/21/1995 | CA2169358A1 A method for displaying proteins |
| 12/20/1995 | EP0687728A2 Reovirus strain 2177 and vaccine containing same |
| 12/20/1995 | EP0687688A1 Antibodies against pneumolysine and their applications |
| 12/20/1995 | EP0687681A1 Immunogens for the production of cocaine-hydrolyzing catalytic antibodies |
| 12/20/1995 | EP0687300A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 12/20/1995 | EP0687295A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 12/20/1995 | EP0687272A1 Method and compositions for recombinant osteogenic protein production |
| 12/20/1995 | EP0687183A1 Synergistic composition of cd4-based protein and anti-hiv-1 antibody, and methods of using same |
| 12/20/1995 | EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
| 12/20/1995 | EP0462115B1 A diagnostic protein marker for bladder cancer |
| 12/20/1995 | EP0394424B1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes |
| 12/20/1995 | CN1113518A A novel peptide related to human programmed cell death and DNA encoding it |
| 12/19/1995 | US5476939 Immunoassay for metal ions; forming coordination complexes |
| 12/19/1995 | US5476849 Methods for glycosylation inhibition using amino-benzoic acids and derivatives |
| 12/19/1995 | US5476839 Variable N-terminal sequences; useful in the diagnosis and treatment of disease |
| 12/19/1995 | US5476786 Host cell harboring and capable of expressing DNA encoding single chain recombinant polypeptide having site for binding preselected antigen |
| 12/19/1995 | US5476784 Medical diagnosis |
| 12/19/1995 | US5476782 DNA encoding a human 5-HT1E receptor and uses thereof |
| 12/19/1995 | US5476778 Method of growing and attenuating a viral agent associated with mystery swine disease |
| 12/19/1995 | CA1337756C Means and method for preventing and treating graft failure in humans |
| 12/19/1995 | CA1337755C Monoclonal antibodies for human non-small cell lung carcinomas |